Global Structural Heart Imaging (SHI) Market to Reach US$45.8 Billion by 2030
The global market for Structural Heart Imaging (SHI) estimated at US$26.7 Billion in the year 2024, is expected to reach US$45.8 Billion by 2030, growing at a CAGR of 9.4% over the analysis period 2024-2030. Echocardiogram, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$27.5 Billion by the end of the analysis period. Growth in the MRI segment is estimated at 9.9% CAGR over the analysis period.
The U.S. Market is Estimated at US$6.9 Billion While China is Forecast to Grow at 12.7% CAGR
The Structural Heart Imaging (SHI) market in the U.S. is estimated at US$6.9 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$10.5 Billion by the year 2030 trailing a CAGR of 12.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.0% and 7.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.9% CAGR.
Global Structural Heart Imaging (SHI) Market - Key Trends and Drivers Summarized
How Is Structural Heart Imaging Transforming Cardiac Care?
Structural Heart Imaging (SHI) is a critical aspect of modern cardiology, providing detailed visualization of the heart’s structure, including valves, chambers, and surrounding vessels. This imaging technique plays a pivotal role in diagnosing and treating structural heart diseases such as valvular heart disease, septal defects, and congenital abnormalities. It encompasses several imaging modalities, including echocardiography, cardiac MRI, CT scans, and 3D imaging, each offering precise visualization to guide minimally invasive procedures like transcatheter aortic valve replacement (TAVR) and mitral valve repair. As the demand for non-invasive cardiac treatments grows, SHI has become indispensable for accurate diagnosis, treatment planning, and patient monitoring in structural heart disease.
What Are the Key Segments in the Structural Heart Imaging Market?
Key modalities include echocardiography, cardiac MRI, computed tomography (CT), and nuclear imaging, with echocardiography holding the largest market share due to its widespread use in real-time heart assessments and pre-procedural planning. Applications cover valvular heart disease, congenital heart defects, cardiomyopathies, and coronary artery disease, with valvular heart disease representing a significant segment driven by the increasing prevalence of aortic stenosis and mitral regurgitation in aging populations. End-users include hospitals, ambulatory surgical centers, and diagnostic imaging centers, with hospitals leading the market as they conduct advanced cardiac imaging for both inpatient and outpatient care.
How Is Structural Heart Imaging Integrated Across Cardiology?
In the diagnosis of valvular heart disease, echocardiography is used to assess valve morphology, function, and blood flow, helping cardiologists determine the severity of stenosis or regurgitation and guide treatment decisions. In congenital heart disease, advanced imaging techniques like cardiac MRI and 3D CT scans offer detailed anatomical visualization, supporting surgical planning and interventional procedures. For patients undergoing transcatheter interventions, SHI is crucial for pre-procedural planning, intraoperative guidance, and post-procedural monitoring, ensuring successful outcomes. Additionally, structural heart imaging aids in risk stratification, enabling physicians to predict complications, monitor disease progression, and tailor interventions for individual patients.
What Factors Are Driving the Growth in the Structural Heart Imaging Market?
The growth in the Structural Heart Imaging market is driven by several factors, including increasing demand for accurate diagnosis and minimally invasive treatment of structural heart diseases. Advancements in imaging technologies, such as real-time 3D imaging, improved resolution, and AI integration, have enhanced diagnostic accuracy, procedural planning, and patient outcomes, supporting broader adoption across cardiology. The focus on managing cardiovascular diseases, particularly in aging populations with valvular disorders, has further fueled demand, as SHI enables early detection, precise interventions, and effective monitoring. Additionally, rising healthcare investments, the expansion of cardiac care facilities, and growing awareness of non-invasive treatments have contributed to market growth, encouraging the integration of advanced imaging techniques in structural heart care.
SCOPE OF STUDY:TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.
We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.
As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.
To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!
APRIL 2025: NEGOTIATION PHASE
Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.
JULY 2025 FINAL TARIFF RESET
Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.
Reciprocal and Bilateral Trade & Tariff Impact Analyses:
USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.
Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook